ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,040.53
-0.50%
US Tech 100
20,778.00
-0.69%
다우존스 지수
44,544.66
-0.75%
Bitcoin
101,936.17
-0.47%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE

  6. Selvita Sa (0RKT) 시세

Selvita Sa

Selvita Sa (0RKT)

LSE
57.00
0.00
(0.00%)
마감 01 2월 1:30AM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
57.00
매수가
0.00
매도가
0.00
거래량
0.00
0.00 일간 변동폭 0.00
57.00 52주 범위 57.00
market_cap
1.318B
전일 종가
57.00
개장가
-
최근 거래 시간
(O)
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
1
발행 주식
23,120,000
배당수익률
-
주가수익률
-14.31
주당순이익(EPS)
-3.98
매출
67.99M
순이익
-92.11M

Selvita Sa 정보

섹터
Chemicals & Chem Preps, Nec
산업
Chemicals & Chem Preps, Nec
웹사이트
ryvu.com
본부
Krakow, Pol
설립됨
-
Selvita Sa is listed in the Chemicals & Chem Preps sector of the 런던증권거래소 with ticker 0RKT. The last closing price for Selvita was PLN57. Over the last year, Selvita shares have traded in a share price range of PLN 57.00 to PLN 57.00.

Selvita currently has 23,120,000 shares in issue. The market capitalisation of Selvita is PLN1.32 billion. Selvita has a price to earnings ratio (PE ratio) of -14.31.

0RKT 최신 뉴스

추가 뉴스

Ryvu Therapeutics presents clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs at the 2024 EORTC-NCI-AACR Symposium

Ryvu Therapeutics presents clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs at the 2024 EORTC-NCI-AACR Symposium PR Newswire KRAKOW, Poland, Oct. 23, 2024...

23 10월 2024
PR Newswire (US)

Ryvu Therapeutics to present clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs at the 2024 EORTC-NCI-AACR Symposium

Ryvu Therapeutics to present clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs at the 2024 EORTC-NCI-AACR Symposium PR Newswire KRAKOW, Poland, Oct. 9, 2024...

09 10월 2024
PR Newswire (US)

Ryvu Therapeutics to present ONCO Prime platform at the 6th Annual RAS-Targeted Drug Development Summit

Ryvu Therapeutics to present ONCO Prime platform at the 6th Annual RAS-Targeted Drug Development Summit PR Newswire KRAKOW, Poland, Sept. 23, 2024 ONCO Prime is a cutting-edge drug discovery...

23 9월 2024
PR Newswire (US)

Ryvu Therapeutics presents clinical and preclinical data on RVU120 at the 2024 European Hematology Association Congress

Ryvu Therapeutics presents clinical and preclinical data on RVU120 at the 2024 European Hematology Association Congress PR Newswire KRAKOW, Poland, June 14, 2024 RVU120 as a single agent showed...

15 6월 2024
PR Newswire (US)

Ryvu Therapeutics to Present Preclinical Data on RVU120 and Synthetic Lethality Programs at the 2024 AACR Annual Meeting

Ryvu Therapeutics to Present Preclinical Data on RVU120 and Synthetic Lethality Programs at the 2024 AACR Annual Meeting PR Newswire KRAKOW, Poland, March 6, 2024 Updated preclinical data will be...

06 3월 2024
UK Regulatory

Ryvu Announces Dosing of the First Patient in the RIVER-52 Phase II Study of RVU120 as a Monotherapy for the Treatment of Patients with Relapsed/Refractory AML and HR-MDS

Ryvu Announces Dosing of the First Patient in the RIVER-52 Phase II Study of RVU120 as a Monotherapy for the Treatment of Patients with Relapsed/Refractory AML and HR-MDS PR Newswire KRAKOW...

15 2월 2024
UK Regulatory

Ryvu Therapeutics to Present Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Meeting

Ryvu Therapeutics to Present Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Meeting PR Newswire KRAKOW, Poland, Nov. 2, 2023 Updated data from the Phase I trial of RVU120...

03 11월 2023
PR Newswire (US)

Ryvu Therapeutics Reports 2022 Half-Year Financial Results and Provides Corporate Update

Ryvu Therapeutics Reports 2022 Half-Year Financial Results and Provides Corporate Update PR Newswire KRAKOW, Poland, Sept. 28, 2022 KRAKOW, Poland, Sept. 28, 2022 /PRNewswire/ -- Ryvu...

29 9월 2022
PR Newswire (US)

Ryvu Therapeutics Presents Updated Clinical and Preclinical Data on RVU120 at the 2022 European Hematology Association (EHA) Congress

Ryvu Therapeutics Presents Updated Clinical and Preclinical Data on RVU120 at the 2022 European Hematology Association (EHA) Congress PR Newswire KRAKOW, Poland, June 10, 2022 - Clinically...

10 6월 2022
PR Newswire (US)

Ryvu Therapeutics to Present Data from its Oncology Programs at AACR 2022 Annual Meeting

Ryvu Therapeutics to Present Data from its Oncology Programs at AACR 2022 Annual Meeting PR Newswire KRAKOW, Poland, March 8, 2022 KRAKOW, Poland, March 8, 2022 /PRNewswire/ -- Ryvu Therapeutics...

09 3월 2022
PR Newswire (US)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10057575700DE
40057575700DE
1200575757157DE
2600575757157DE
5200575757057DE
15600575757057DE
26000575757057DE

0RKT - Frequently Asked Questions (FAQ)

What is the current Selvita share price?
The current share price of Selvita is PLN 57.00
How many Selvita shares are in issue?
Selvita has 23,120,000 shares in issue
What is the market cap of Selvita?
The market capitalisation of Selvita is PLN 1.32B
What is the 1 year trading range for Selvita share price?
Selvita has traded in the range of PLN 57.00 to PLN 57.00 during the past year
What is the PE ratio of Selvita?
The price to earnings ratio of Selvita is -14.31
What is the cash to sales ratio of Selvita?
The cash to sales ratio of Selvita is 19.38
What is the reporting currency for Selvita?
Selvita reports financial results in PLN
What is the latest annual turnover for Selvita?
The latest annual turnover of Selvita is PLN 67.99M
What is the latest annual profit for Selvita?
The latest annual profit of Selvita is PLN -92.11M
What is the registered address of Selvita?
The registered address for Selvita is ST. LEONA HENRYKA STERNBACHA 2, KRAKOW, 30-394
What is the Selvita website address?
The website address for Selvita is ryvu.com
Which industry sector does Selvita operate in?
Selvita operates in the CHEMICALS & CHEM PREPS, NEC sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
AIQAiq Limited
4.00p
(33.33%)
37.88k
INSPInspirit Energy Holdings Plc
0.0036p
(28.57%)
1.43B
ALKAlkemy Capital Investments Plc
175.00p
(27.27%)
176.27k
KNBKanabo Group Plc
1.00p
(25.00%)
461.04k
TCFTheracryf Plc
1.125p
(25.00%)
6.72M
MET1Metals One Plc
0.275p
(-35.29%)
16.2M
PPSProton Motor Power Systems Plc
0.175p
(-22.22%)
848.7k
SYMESupply@me Capital Plc
0.0025p
(-19.35%)
372.49M
CGNRConroy Gold & Natural Resources Plc
2.15p
(-18.87%)
739.53k
ONCOncimmune Holdings Plc
10.40p
(-16.47%)
1.19M
INSPInspirit Energy Holdings Plc
0.0036p
(28.57%)
1.43B
NTVONativo Resources Plc
0.0018p
(-5.26%)
1.41B
MSMNMosman Oil And Gas Limited
0.041p
(10.81%)
1.22B
TRPTower Resources Plc
0.0295p
(0.00%)
691.76M
SYMESupply@me Capital Plc
0.0025p
(-19.35%)
372.49M

토론

전체 피드 보기
MoCubano MoCubano 7 분 전
Excellent!
FNMA
Kam8 Kam8 9 분 전
I thought MMs would like to pay Billion to nwbo instead of discovery. 
NWBO
Seminole Red Seminole Red 12 분 전
I have 4- 8's, wish we were playing poker...
Golfbum22 Golfbum22 20 분 전
Another expert put on ignore
FNMA
Looking4aprofit Looking4aprofit 23 분 전
Of course he would show up…he is NWBO shareholders’ guardian angel, has no shares but here (24/7) to protect us from the “incompetent “ management and forestall us from continuing to support a “failed trial” company! Thanks Jerry for your altruistic endeavours.

Don’t act the fool Jer
NWBO
Money hunt Money hunt 32 분 전
With TTX Ai platform, Yes RNAZ can
Can Trump-backed Stargate project beat ‘The Big C’?

The tech is expected to help create a cancer vaccine in just 48 hours.

US President Donald Trump has unveiled a $500b joint venture among Oracle Corp., OpenAI, and Softbank Gro
RNAZ
Peter J Peter J 35 분 전
LOL @abbadoc
I have no problem with Krom or others getting out of this with a profit....just get it the old fashion way....earn it thru company accomplishments.

Sir, I can only say: FOS.

An examply why this is FOS, a quote from a Tullow oil investor, how strinki
ERHE
Jimmy Joe Jimmy Joe 38 분 전
Just watched the Lamont Roach/McCrory fight. Like McCrory Shorts just over played themselves into a MASSIVE
financial eff up aka a cluster eff.

Didn't have anything close to the nuts but tried to bluff their way through the river card. Oppps~!

I see panic on thi
AMC
Angelmin Angelmin 39 분 전
Following the confirmation of Treasury Secretary Scott, Bessent devoted all his time to purchasing a luxurious house in DC. Here is his $12.5 million villa.


Hope he has time for us.
FNMA
XMaster2023 XMaster2023 51 분 전
Dude, I don’t get paid to lie like you. As long as discovery proceeds I’m ecstatic. The market Makers will lose.
NWBO
martyDg martyDg 51 분 전
why should I celebrate a 1.3 cents up when in fact it was down from .30 last week?
NWBO
DruidOracle55 DruidOracle55 53 분 전
finally , great!
ONAR
DruidOracle55 DruidOracle55 53 분 전
finally , great!
ONAR
Seminole Red Seminole Red 53 분 전
I dont read Huffington post, its a dem rag
236T568 236T568 53 분 전
The world is watching...

https://bsky.app/profile/janeotn.bsky.social/post/3lh3j2pc4622q
XMaster2023 XMaster2023 54 분 전
Must be related to AF.
The blogger who helped spark Nvidia’s $600 billion stock collapse and a panic in Silicon Valley Jeffrey Emanuel
The only difference is Jeffrey, might be correct, where AF is just a paid hit man who spreads lies.
NWBO
DruidOracle55 DruidOracle55 1 시간 전
very funny
AXXA
nwtf nwtf 1 시간 전
Thing is you cant prove there is one share shorted in Canada. So youre lying again.
ERHE
LuckyPanda LuckyPanda 1 시간 전
Maybe we can report this wasteful lawsuit for Libor by FDIC to DOGE. We need to end these silly Liibor lawsuit that will go nowhere and close the receivership!!!!
COOP
236T568 236T568 1 시간 전
Oh my...and about those tariffs....

https://x.com/HedyLamarr0629/status/1885531074484175162
LuckyPanda LuckyPanda 1 시간 전
I'm 100% positive money is coming to old escrow owners...Why else would the FDIC go through so much trouble to not close the receivership after 16 years?? However I'm not sure if I will ever see this money. I'm now 48 and I have a feeling I will retire before the receivership closes. Maybe my son w
COOP
lovethatgreen lovethatgreen 2 시간 전
Myself as well but at 32

Small OS atm
DanM51 DanM51 2 시간 전
"Maybe you should join me in a squirrel suit"....I think we all suspected Spartex was a Furry.🦫🐿
LWLG
raggi65 raggi65 2 시간 전
Dragoon, some clocks tick differently; only in 2040 will Lodas be eligible for a midlife crisis and Jamie get his wisdom teeth.
But in 2040, science will be so advanced that the most important figures in human history, namely Lenin, Kissinger and Lord Rothschild, can be brought back to life
COOP

최근 히스토리

LSE
0RKT
Selvita
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지